Home › Targets › NLRP3

NLRP3 (1 companies · 2 programs)

Companies with an active program directed at NLRP3.

BioAge Labs, Inc. BIOA

BGE-102 — Atherosclerotic Cardiovascular Disease Phase 1
BGE-102 — Diabetic Macular Edema Phase 1